Alcon Launches UNITY M Ophthalmic Microscope for Enhanced Surgical Precision
Geneva, Switzerland — September 2026 Alcon announced the commercial launch of UNITY® M, a premium ophthalmic surgical microscope designed...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Geneva, Switzerland — September 2026 Alcon announced the commercial launch of UNITY® M, a premium ophthalmic surgical microscope designed...
Cambridge, Massachusetts — September 3, 2026 eGenesis announced an important clinical update from its ongoing Expanded Access study of...
